What's happening
Summary being written. Track this bill to get it by email.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Create Antibiotic Resistance Office
Plain English, a few words. Used as the page title.
Sponsors
2 Co-sponsors
History
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Create Antibiotic Resistance Office
In Senate Committee · Health · Sponsor Brian Kavanagh
Full text
10 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
10097
IN ASSEMBLY
April 29, 2022
Introduced by M. of A. L. ROSENTHAL, ENGLEBRIGHT, SIMON -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to establishing an office of antibiotic-resistance control; to amend the state finance law, in relation to establishing the antibiotics education fund; and to amend the labor law, in relation to including methicillin-resistant staphylococcus aureus (MRSA) and other antibiotic-resistant infections in the definition of airborne infectious disease
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Legislative findings. Antibiotics are rightfully considered one of the medical miracles of the last century because of their powerful ability to fight illness and disease caused by bacteria. But the effectiveness of medically important antibiotics is now at great risk due to their misuse and overuse in medicine and agriculture. Many strains of bacteria have evolved resistance to antibiotics, meaning instead of being killed by the drugs, they survive, multiply, and spread. In fact, the more antibiotics are used, the faster antibioticresistant bacteria (aka "superbugs") emerge, increasing the risk of contracting an antibiotic-resistant infection. If effective policy measures are not soon adopted, some experts predict that by 2050, antibiotic-resistant infections will be responsible for more annual deaths than cancer.
In recognition of the serious public health threat posed by antibiotic-resistant infections, the United Nations General Assembly in 2016 committed to taking action. The World Health Organization (WHO) considers it to be one of the biggest threats to global health, food security, and international development today. The United States Centers for Disease Control and Prevention (CDC) has stated that fighting this threat is a public health priority and estimates that each year, antibiotic-resistant bacteria are responsible for at least 2.8 million infections in the United States and at least 35,000 deaths. A study commissioned by the United Kingdom government predicts that if action is not taken now to combat antibiotic resistance, by 2050 the annual death
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD14978-02-2
toll will have risen to 10 million globally. Most major medical and health groups in the United States, including the American Medical Association, American Academy of Pediatrics, and Infectious Diseases Society of America, have recognized the urgency of the antibiotic-resistance crisis. New York State, in its Prevention Agenda 2019-2024, established Antibiotic Resistance and Healthcare-Associated Infections as one of five major focus areas.
Antibiotic-resistant bacteria are bacteria that are immune to the effect of antibiotics. These so-called "superbugs" can infect humans and animals, and the infections they cause are harder and sometimes impossible to treat. Antibiotic resistance is a naturally occurring phenomenon, but the speed at which superbugs are emerging and spreading is accelerating due to overuse and misuse of antibiotics in humans and animals. Antibiotic-resistant bacteria are most prevalent in environments associated with high antibiotic use: healthcare settings and animal agriculture. Two-thirds of all medically important antibiotics are sold for use in animals. Bacteria that are resistant can spread from person to person, and from animal to person--via the natural environment or contaminated food--and resistance genes can transfer from bacteria to bacteria. Some bacteria have developed resistance to multiple antibiotics, making common infectious diseases such as tuberculosis, pneumonia, food poisoning, urinary tract infections (UTIs), and gonorrhea harder and sometimes impossible to treat. Everyone is at risk of exposure to antibiotic-resistant bacteria, but those who work in hospitals and nursing homes, patients in such facilities, and those who work in livestock farming, slaughterhouses, and large animal veterinarian practices have a greater risk of getting antibiotic-resistant infections.
Given the current and growing threat posed by antibiotic resistance, the state of New York must organize itself to adequately respond. The WHO and the CDC recommend taking a "One Health" approach, which recognizes the interconnectedness of humans and animals in achieving optimal health outcomes.
§ 2. Article 2 of the public health law is amended by adding a new title 9 to read as follows:
TITLE 9
ANTIBIOTIC-RESISTANCE CONTROL Section 269-a. Statement of policy and purposes.
269-b. Definitions.
269-c. Office of antibiotic-resistance control.
269-d. Antibiotic-resistance control board.
269-e. Organization of antibiotic-resistance control board.
269-f. Meetings.
269-g. Functions, powers and duties.
269-h. Cooperation with other departments.
269-i. Evaluation requirements.
269-j. Antibiotic-resistance data collection.
269-k. Antibiotic stewardship implementation.
269-l. Antibiotic-resistance control in agriculture.
269-m. Reporting requirements.
269-n. Violations.
§ 269-a. Statement of policy and purposes. The purpose of this title is to codify the establishment of an office to organize the state's efforts to control the spread of antibiotic resistance, coordinate all agencies' responses, and rely on best practices to comprehensively address the public health threat posed by antibiotic resistance.
§ 269-b. Definitions. As used in this section:
1. "Antibiotic" means a drug used to treat infections caused by bacteria. Antibiotics may either kill or inhibit the growth of bacteria.
2. "Antibiotic class" means antibiotic agents with related molecular structures, often with a similar mode of action because of interaction with a similar target and thus subject to a similar mechanism of resistance.
3. "Antibiotic resistance" means the ability of a bacterium to multiply or persist in the presence of an increased level of an antibiotic relative to the susceptible counterpart of the same species.
4. "Antibiotic stewardship" means using the optimal selection, dosage, and duration of antibiotic treatment that results in the best clinical outcome for the treatment of infection, with minimal toxicity to the patient and minimal impact on subsequent resistance. Antibiotic stewardship may also include measures to prevent spread of infection in hospitals and animal husbandry practices that prevent spread of infections on farms.
5. "Board" means the antibiotic-resistance control board created pursuant to section two hundred sixty-nine-d of this title.
6. "Disease control" means administration of antibiotics to a group of animals once a proportion of the animals in the group have been diagnosed (based on clinical signs or other appropriate diagnostic methods) with an indicated disease.
7. "Disease prevention" means administration of antibiotics to a group of animals, none of which have been diagnosed with an indicated disease, when transmission of existing undiagnosed infections, or the introduction of pathogens, is anticipated based on history, clinical judgment, or epidemiological knowledge.
8. (a) "Disease treatment" means administration of an antibiotic only to animals diagnosed (based on clinical signs or other appropriate diagnostic methods) with an indicated disease.
(b) Disease treatment includes but is not limited to selective dry cow therapy, whereby individual dairy cows within a herd are determined, when entering a dry cycle, to be likely infected with mastitis based on key indicators including their previous history of disease, somatic cell counts and/or cell cultures, and are administered antibiotics as prescribed by a licensed veterinarian.
9. "Foodborne disease" (also referred to as foodborne illness or food poisoning): means any illness that results from the consumption of food, contaminated with pathogenic bacteria, viruses, or parasites.
10. "Food-producing animal" means:
(a) All cattle, swine, or poultry, regardless of whether the specific animal is raised for the purpose of producing food for human consumption; or
(b) Any animal of a type that the department of agriculture and markets identifies by rule as livestock typically used to produce food for human consumption, including aquatic and amphibian species.
11. "Livestock producer" means a person raising a food-producing animal for commercial purposes.
12. "Medically important antibiotic" means a drug that is composed in whole or in part of:
(a) A form of the antibiotic classes of penicillin, tetracycline, macrolide, lincosamide, streptogramin, aminoglycoside, sulfonamide, fluoroquinolones, amphenicols, polymyxins, or cephalosporin; or
(b) A drug from an antibiotic class that is categorized as critically important, highly important, or important in the World Health Organization list of critically important antimicrobials for human medicine (6th revision, 2019), or a subsequent revision or successor document issued by the World Health Organization that is recognized by rule by the department.
13. "Office" means the office of antibiotic-resistance control created pursuant to section two hundred sixty-nine-c of this title.
14. "One Health" means taking a collaborative, multisectoral, and transdisciplinary approach to controlling antibiotic resistance, recognizing the interconnection between people, animals, plants, and their shared environment.
15. "Veterinary feed directive" has the same definition as in section 558.3 of title 21 of the code of federal regulations.
§ 269-c. Office of antibiotic-resistance control. There is hereby created within the department an office of antibiotic-resistance control. Such office shall:
1. Integrate and coordinate selected state health antibiotic-resistance monitoring, oversight, and education programs based on the centers for disease control's One Health approach to combating antibiotic resistance. As part of this function, the office shall develop a coordinated, comprehensive strategy and plan to end the misuse and reduce the overuse of antibiotics in medicine and agriculture in the state. In line with the National Action Plan 2020-2025 created by the Federal Task Force on Combating Antibiotic-Resistant Bacteria, the office shall have a goal for the state of reducing health care-associated antibiotic-resistant infections by twenty percent by two thousand twenty-five and community-acquired antibiotic-resistant infections by ten percent by two thousand twenty-five. It shall have a further goal, consistent with the existing goal of the European Union, of reducing use of medically important antibiotics in food animal production by fifty percent within five years after the effective date of this title, using a baseline established two years after the effective date of this title.
2. Apply for grants, and accept gifts from private and public sources, for research to improve the appropriate use of antibiotics.
3. Together with the antibiotic-resistance control board, serve as liaison and advocate on matters relating to the judicious use, unnecessary use, and misuse of antibiotics. This function shall include the provision of staff support to the antibiotic-resistance control board and the establishment of appropriate program linkages with related federal, state, and local agencies and programs.
4. Assist medical schools, veterinarian schools, agricultural schools, and state agencies in the development of antibiotic-resistance control training programs for doctors, veterinarians, medical and veterinary support staff, and farmers, and in the development of educational coursework for medical, veterinary, and agricultural students.
5. Promote community strategic planning and new or improved health care delivery systems to reduce the use of antibiotics in health care settings and agricultural settings.
6. Review the impact of antibiotic-resistance control programs and regulations on levels of antibiotic-resistant bacteria found in health care settings and agricultural settings, and that are foodborne.
§ 269-d. Antibiotic-resistance control board. 1. An antibiotic-resistance control board is hereby created. Such board shall have five voting members, who shall be the commissioners of health, agriculture and markets, environmental conservation, education, and a public member. In addition, as advisory members, there shall be a dean of a New York state medical college, a dean of a New York state veterinary college, two epidemiologists with expertise in antibiotic resistance, and, six members, to be appointed by the governor, however, two shall be upon the recommendation of the speaker of the assembly and two shall be upon the recommendation of the temporary president of the senate. At least one of the six members shall be a representative of the pharmaceutical industry, one a representative of the farming community, and four representatives of the public with relevant expertise in, but not limited to, the fields of public health, patient experience, or antibiotic resistance. To the extent practicable, these public members shall be representative of the diversity of the state.
2. Advisory members appointed by the governor shall serve for terms of three years, such terms to commence on July first and to expire on June thirtieth; provided, however, that of the advisory members first appointed, two shall be appointed for a one-year term expiring one year after the effective date of this title, two shall be appointed for a two-year term expiring two years after the effective date of this title, and the remaining two shall be appointed for full three-year terms. Each such advisory member shall hold office until a successor shall have been appointed and qualified.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.